R.E.D. Institut fuer medizinische Studien und Fortbildung GmbH — Clinical Trial Site

34 Registered trials

10 Currently recruiting

Organisation

R.E.D. Institut fuer medizinische Studien und Fortbildung GmbH

Location

Oldenburg In Holstein, Germany

Identifier

ORG-100040953

Address

Markt 15, 23758, Germany

Departments

-
DE018
Geschaeftsfuehrung
Institut
Institut für Med. Forschung und Fortbildung Innere Medizin/Diabetologie
internal medicine, diabetology
N/A
NA
Praxis für Gastroenterologie, Kronsforder Allee 69, 23560 Lübeck
private practice
R.E.D. Institut
R.E.D. Institut fuer medizinische Studien und Fortbildung GmbH
RED Institut
RED-Institut
RED-Institut GmbH

Clinical trials at this site (34)

Search interface

A Study to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Influenza Vaccine Compared with a Licensed Influenza … Ended

2024-516240-26-00 Influenza 5 2024-10-11
A research study comparing how well different doses of the medicine NNC0487-0111 lower blood sugar in people with type 2 diabetes Ended

2023-509412-28-00 Type 2 Diabetes 4 2024-07-26
A Research Study to See How Switching from a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar … Ended

2023-506084-34-00 Type 2 Diabetes 5 2024-04-12
A study to test whether BI 456906 helps people living with overweight or obesity who do not have diabetes to lose weight Ended

2022-502529-17-00 Obesity 5 2024-01-18
A study to test whether BI 456906 helps people living with overweight or obesity who also have diabetes to lose weight Ended

2022-502531-18-00 Obesity 5 2024-01-18
REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight… Ended

2022-502678-18-00 Type 2 diabetes 5 2023-11-07
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) Ended

2022-500101-41-00 Type 2 Diabetes 6 2023-06-07
A study to evaluate ExPEC9V vaccine for the prevention of Invasive E. coli Disease in adults aged 60 years and older with a history of urina… Ended

2023-506589-30-00 Invasive Extraintestinal Pathogenic Escherichia coli Di 5 2022-02-09
Evaluating the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age Ended

2023-508820-37-00 Cytomegalovirus Infection (CMV) 5 2022-02-03
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24